Vascepa

Drug - Vascepa [Amarin Pharma, Inc.]

June 2013

Therapeutic area - Cardiovascular

Approval criteria

Patient has a documented triglyceride level >1000 mg/dL AND
Patient has tried and failed fenofibrate AND
Patient has tried and failed Lovaza

Questions?

MHCP Provider Call Center 651-431-2700 or 800-366-5411